Sherbrooke Park Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,673
Closed -$480K 399
2025
Q3
$480K Buy
1,673
+681
+69% +$182K 0.22% 180
2025
Q2
$260K Sell
992
-691
-41% -$168K 0.11% 332
2025
Q1
$392K Buy
+1,683
New +$408K 0.18% 207
2024
Q4
Sell
-1,354
Closed -$303K 986
2024
Q3
$303K Buy
+1,354
New +$298K 0.07% 562
2024
Q2
Sell
-2,087
Closed -$456K 1072
2024
Q1
$456K Buy
+2,087
New +$460K 0.09% 394

Other funds holding LH

Sherbrooke Park Advisers's LH Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Labcorp (LH) in Q4 2025, closing a stake of 1,673 shares — an estimated $480K sold.

Sherbrooke Park Advisers first reported a position in LH in Q1 2024 and held it in 5 quarters. The position peaked at $480K in Q3 2025. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,673 Labcorp shares in Q4 2025, an estimated $480K.
  • Sherbrooke Park Advisers first reported a position in Labcorp in Q1 2024 and held it in 5 quarters.
  • Sherbrooke Park Advisers's Labcorp position peaked at $480K in Q3 2025.
  • 1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.